We’re proud to be nominated in the ‘Company’ category of the #21toWatch Awards 2026, which celebrate the innovators and businesses shaping the future of Cambridge and the East of England.
Our nomination reflects our pioneering AI-driven, carbon-positive drug discovery and plant-based engineering platform – a plug-and-play system currently being deployed into adjuvants and transforming vaccine development.
By combining advanced AI with plant bioengineering, we’re creating novel molecules and hard-to-source adjuvants, delivering next-generation therapeutics sustainably and at scale. Our environmentally responsible production model ensures a long-term, resilient supply of complex compounds – without depleting natural resources or harming ecosystems.
“HotHouse Therapeutics has been in stealth mode since its launch in July 2024 and now seems the perfect time to appear on the #21toWatch list as we exit stealth and embark on our next funding round,” said Dr David Sheppard, CEO of HotHouse Therapeutics.
Read more here.
Back